Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9200002 Compositions useful for treating disorders related to KIT

Patent 9200002 was granted and assigned to Blueprint Medicines on December, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

Blueprint Medicines

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

December 1, 2015

0

Patent Application Number

145153270

Date Filed

October 15, 2014

0

Patent Citations Received

US Patent 12060354 Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of making

0

US Patent 11963958 RET inhibitor for use in treating cancer having a RET alteration

0

US Patent 11964980 Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1- f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of making

0

US Patent 11999744 Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of making

0

US Patent 11872192 RET inhibitor for use in treating cancer having a RET alteration

0

Patent Primary Examiner

Venkataraman Balasubramanian

0

Patent abstract

Compounds and compositions useful for treating disorders related to mutant KIT are described herein.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9200002 Compositions useful for treating disorders related to KIT

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool